From Lab to Global Markets: HYHC’s Patent Portfolio in Sleep Tech

HYHC holds 34 patents (8 inventions) covering graphene synthesis, IoT protocols, and medical safety standards. Key IP assets include:

Patent 1: Dynamic Pressure Therapy System (CN202410238765.8)

• Technology: Air pumps + graphene sensors auto-adjust eye mask compression (15-25mmHg)
• Benefit: Reduces intraocular pressure by 18% in glaucoma-risk users

Patent 2: Self-Cleaning Graphene Fabric (US202436789A1)

• Innovation: TiO2 nanoparticle coating enables UV sterilization during washing
• Performance: 99.2% antibacterial rate (E. coli/S. aureus) per AATCC 100 tests

Patent 3: Cross-Platform Health API (EP4123378A4)

• Function: Unifies sleep data from HYHC masks/Fitbit/Apple Health into HIPAA-compliant dashboards
• Application: Used by Mayo Clinic in remote patient monitoring trials

Strategic Partnerships

HYHC collaborates with:

• Material Science: Tsinghua University on graphene conductivity enhancements
• Medical Institutions: Shenzhen Hospital for TCM-acupuncture hybrid therapies
• Retail: Amazon’s Launchpad program for DTC brand incubation

Industry Recognition

• 2024 Red Dot Award: HYHC ZenSleep Pro Eye Mask
• Forbes China 'Top 10 Healthtech Startups' (2023-2025)
• Annual R&D investment: 15% of revenue ($8.7 million in 2024)